Commodore Capital, 10% Owner: Enliven Therapeutics ELVN Buy · Filed 23/02/27

Trade details

Type: Insider buy
Amount: $13,722.02
Shares · price: 621.75 sh · $22.07 a share
Held after: 718,749 sh
Stock: Enliven Therapeutics ELVN
Person: Commodore Capital10% Owner
Trade date: 23/02/23
Filed: 23/02/27
Days to filing: 4 days

Holdings up 0.1%

Insiders buying this week: 1 insiders
Holding change: +0.1%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/24~23/03/25

Commodore Capital's recent trades

Commodore Capital10% Owner
SellVera Therapeutics
Sell
Vera Therapeutics
VERA
$18.9M
1,050,000 sh
$18.9M
Filed 24/01/12
Traded 24/01/10
Commodore Capital10% Owner
BuyVistagen Therapeutics
Buy
Vistagen Therapeutics
VTGN
$18M
775,756 sh
$18M
Filed 23/08/09
Traded 23/08/07
Commodore Capital10% Owner
BuyVera Therapeutics
Buy
Vera Therapeutics
VERA
$6.8M
448,217 sh
$6.8M
Filed 23/06/22
Traded 23/06/20
Commodore Capital10% Owner
BuyEnliven Therapeutics
Buy
Enliven Therapeutics
ELVN
$120.4K
23,565 sh
$120.4K
Filed 23/02/23
Traded 23/02/22
Commodore Capital10% Owner
BuyEnliven Therapeutics
Buy
Enliven Therapeutics
ELVN
$43K
8,194 sh
$43K
Filed 23/02/23
Traded 23/02/21